The Trump administration is preparing to announce a deal this week with Eli Lilly and Novo Nordisk to lower the price of ...
Everyday Health on MSN
Experimental Obesity Drug Could Soon Compete With Wegovy and Zepbound
Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone amylin that slows digestion and reduces hunger.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback